Anavex Life Sciences Corp.

In the quarter to June 2026, EPS grew 150.0% and free cash flow grew 27.0%, each against the same quarter a year earlier.

1.31 0.17 −11.49%

Follow AVXL

Alert me

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	(43.11%)	(33.63%)	(30.78%)	(12.80%)
ROA Full definition →		(38.75%)	(31.08%)	(27.73%)	(11.70%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(48.89%)	(31.55%)	(28.01%)	(11.58%)
Average Days of Receivables Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		(0.46)	(0.38)	(0.35)	(0.32)
Free Cash Flow Full definition →		(39.04)	(34.07)	(32.66)	(29.29)
Other line items
Cash ROIC Full definition →		(19.77%)	(13.19%)	(13.11%)	(12.69%)
Accounts Receivable Turnover Full definition →		0.00	0.00	0.00	0.00
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Operating CF/Net income Full definition →		0.84	0.85	0.96	2.25
Revenue per Share Full definition →		0.00	0.00	0.00	0.00
Operating CF per Share Full definition →		(0.46)	(0.38)	(0.35)	(0.32)
Capex per Share Full definition →		0.00	0.00	0.00	0.00

Columns are period end dates